PD‐1 expression affects cytokine production by ILC2 and is influenced by peroxisome proliferator‐activated receptor‐γ-Reference-Cited by-同舟云学术

PD‐1 expression affects cytokine production by ILC2 and is influenced by peroxisome proliferator‐activated receptor‐γ

Published:2019-11-19 Issue:1 Volume:8 Page:8-23
ISSN:2050-4527
Container-title:Immunity, Inflammation and Disease
language:en
Short-container-title:Immun Inflamm Dis

Author:

Batyrova Banu¹,Luwaert Fien¹^ORCID,Maravelia Panagiota¹,Miyabayashi Yuria¹,Vashist Neha¹²,Stark Julian M.³^ORCID,Soori Sara Y.¹,Tibbitt Christopher A.¹³^ORCID,Riese Peggy²,Coquet Jonathan M.³^ORCID,Chambers Benedict J.¹^ORCID

Affiliation:

1. Department of Medicine, Centre for Infectious Medicine (CIM), Karolinska Institute Karolinska University Hospital Huddinge Stockholm Sweden

2. Department of Vaccinology and Applied Microbiology Helmholtz Centre for Infection Research Braunschweig Germany

3. Department of Microbiology, Tumor and Cell Biology (MTC) Karolinska Institute Stockholm Sweden

Funder

Cancerfonden

Vetenskapsrådet

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/iid3.279

Reference49 articles.

1. Innate lymphoid cells — how did we miss them?

2. Differentiation and diversity of subsets in group 1 innate lymphoid cells;Seillet C;Int Immunol,2016

3. Group 3 innate lymphoid cells (ILC3s): Origin, differentiation, and plasticity in humans and mice

4. TH2, allergy and group 2 innate lymphoid cells

5. Type 2 innate lymphoid cells-new members of the “type 2 franchise” that mediate allergic airway inflammation

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting PD-1/PD-L1 in tumor immunotherapy: Mechanisms and interactions with host growth regulatory pathways;Cytokine & Growth Factor Reviews;2024-10

2. Bone Marrow-Derived C-Kit+ Cells Improved Inflammatory IL-33/ST-2/ILC2 Axis in the Lung Tissue of Type 2 Diabetic Rats;Applied Biochemistry and Biotechnology;2024-03-13

3. Case report: Sustained complete remission with all-oral MEPED therapy in a patient with Hodgkin’s disease developing resistance to pembrolizumab;Frontiers in Pharmacology;2024-02-20

4. Roles of PPAR activation in cancer therapeutic resistance: Implications for combination therapy and drug development;European Journal of Pharmacology;2024-02

5. Bone marrow-derived C-kit⁺ cells improved inflammatory IL-33/ST-2/ILC2 axis in the lung tissue of type 2 diabetic rats;2023-12-28